CD8A and neoplasm: Notably, as a cGAS agonist, Mn2+ has been demonstrated to be powerful anti-tumor agents by promoting the proliferation of CD8+ T cells and natural killer cells, as well as the maturation and antigen presentation of dendritic cells, in a cGAS-dependent manner.